Thierry Lecomte

10PUBLICATIONS
89CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Genetically modified horticulture plantsMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 27, 2026
Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.

|Nov 04, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.

Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade

|Aug 06, 2025
The piggyBac derived transposase 5 (PGBD5) can interact with human piggyBac-like elements.

Linda Beauclair, Laura Helou, Florian Guilllou

|May 16, 2025
PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma.

Michel Ducreux, Romain Desgrippes, Yves Rinaldi

|Nov 25, 2024
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET).

Thomas Walter, Thierry Lecomte, Julien Hadoux

|May 06, 2024
FASTOCH: Feasibility of Electronic Patient-Reported Outcomes in Older Patients With Cancer-A Multicenter Prospective Study.

Mathilde Cancel, Carine Sauger, Julie Biogeau

Pageof 2

Frequent Collaborators

3 joint publications

Jean-Baptiste Bachet

3 joint publications

Rosine Guimbaud

3 joint publications

Olivier Bouché

2 joint publications

Céline Desvignes